Vanberra Signal

PhotoPharmics

Curated by Signal

Developer of non-invasive phototherapy for Parkinson's disease

Overview

PhotoPharmics is a developer of non-invasive phototherapy for Parkinson's disease. Its previous investigations with light therapy and Parkinson’s disease have shown improvement in Parkinson’s symptoms. The therapy is designed to be used as an adjunct to drug treatment for Parkinson's disease. It is currently conducting a pivotal investigation at three sites in Amsterdam, Boston, and Salt Lake City to demonstrate the safety and efficacy of specialized phototherapy for Parkinson’s disease.

Key facts

Founded
2011

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Revenue management and medical billing solution for dental practitioners

    Health TechnologyLos Angeles, United States
  • Provider of analytics for healthcare products in cannabis and psilocybin markets

    Health TechnologySan Francisco, United States
  • Provider of appointment management solutions in dental practices

    Health TechnologyBaton Rouge, United States

About PhotoPharmics

What does PhotoPharmics do?

PhotoPharmics is a developer of non-invasive phototherapy for Parkinson's disease.

Where is PhotoPharmics headquartered?

PhotoPharmics is headquartered in American Fork, United States.

When was PhotoPharmics founded?

PhotoPharmics was founded in 2011.

Which sector is PhotoPharmics in?

PhotoPharmics operates in Health Technology.

Who are PhotoPharmics's competitors?

Companies similar to PhotoPharmics include Moore Martini Medical, Aurelius Data, and LocalMed.